Skip to content
Sonic
AI
Sonic
AI
Home
Discover
Ask Sonic
Projects
Use with Claude or ChatGPT
Show me around
Request source or feature
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala H..., Sonic AI
Home
/
Outcomes Rocket
/
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala H...
Outcomes Rocket
Notify me
•
Jun 30, 2026
•
16:22
Interview
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala H...
From
Outcomes Rocket
Deanna Harshbarger
(CEO, Cala Health, guest)
Get the full transcript next time Outcomes Rocket releases an episode
Summary, key quotes, top claims, and the searchable transcript — emailed automatically. No card needed.
Sign up
Executive Summary
Cala Health has developed a non-invasive, wearable bioelectronic therapy (CalaTherapy) that treats tremor by delivering personalized electrical stimulation to the peripheral nerves in the wrist.
The company addresses a significant treatment gap for patients who cannot tolerate pharmaceuticals and are not candidates for invasive procedures like deep brain stimulation.
Cala Health has successfully navigated the complex reimbursement landscape, establishing new codes and securing a local coverage determination with Medicare, a critical milestone for commercialization.
The company is launching its next-generation device, the CalaKick Plus, which will offer new stimulation modes for more personalized and effective therapy for a condition unique to each patient.
Continue your research
Keep pulling the thread on Deanna Harshbarger.
Bioelectronic Medicine & Neuromodulation
Overcoming Reimbursement Hurdles
12
quotes
Transcript
Key Arguments
Analysis
Quotes & Entities
12
Related
Loading transcript...
Processed Jun 30, 2026
Daily intelligence brief →
yt-dlp + mlx-whisper + Gemini